XML 61 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations (Details) - Revenue Benchmark [Member] - Product Concentration Risk [Member]
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Total 100.00% 100.00% 100.00% 100.00%
UNITED STATES        
Disaggregation of Revenue [Line Items]        
Total 74.00% 50.00% 39.00% 65.00%
Outside United States Pharma Services [Member]        
Disaggregation of Revenue [Line Items]        
Total 20.00% 2.00% 23.00% 5.00%
DetermaRx [Member]        
Disaggregation of Revenue [Line Items]        
Total 6.00% 0.00% 3.00% 0.00%
Discontinued Operations Outside United States Licensing [Member]        
Disaggregation of Revenue [Line Items]        
Total 0.00% 48.00% 0.00% 30.00%
Discontinued Operations Determa Rx [Member]        
Disaggregation of Revenue [Line Items]        
Total 0.00% 0.00% 35.00% 0.00%